Radiology societies seek Medicare coverage for CT colonography
Several radiology-related professional societies have joined forces to urge the Centers for Medicare and Medicaid Services to approve national Medicare coverage for CT colonography to screen patients for colorectal cancer.
Several radiology-related professional societies have joined forces to urge the Centers for Medicare and Medicaid Services to approve national Medicare coverage for CT colonography to screen patients for colorectal cancer.
The American College of Radiology, the Society of Gastrointestinal Radiologists, and the Society of Computed Body Tomography and Magnetic Resonance sent CMS a joint comment letter June 18 requesting reimbursement for CTC providers. The document states that there are sufficient data and clinical evidence to support the claim.
The comment letter cites recent American Cancer Society guidelines, which add CTC to the ACS list of recommended options for colorectal cancer screening. The guidelines, developed jointly with the ACR and the U.S. Multi-Society Task Force on colorectal cancer, emphasize cancer prevention as the primary goal of colorectal screening. The new ACS rules contend there is compelling evidence of CTC's preventive value for average-risk patients 50 years and older.
The letter also points out recent research data showing CTC's viability as a screening option, including the ACR's Imaging Network National CT Colonography Trial (ACRIN 6664). The ACRIN study found CTC compares favorably with colonoscopy, the current gold standard for screening.
"The trial concludes that CTC accurately detects colorectal neoplasia among average-risk persons and that broad application of this relatively noninvasive technique as a primary test option appears highly feasible and may serve to enhance compliance with current colorectal cancer screening recommendations," the letter said.
The document bears the signatures of ACR executive director Dr. Harvey L. Neiman, SGR president Dr. Richard M. Gore, and SCBT-MR past president Dr. Jeffrey C. Weinreb.
The letter provides CMS with an overview of more than a decade's worth of clinical trials leading to CTC's validation, including direct comparisons between CTC and colonoscopy. It also mentions the current clinical practice guidelines observed by CTC providers, including appropriateness criteria, quality and safety assurance, and radiation dose.
In separate sections, the letter to CMS also offers a glance at the cost-effectiveness of the CT-based screening procedure, the patient population best suited for the test, and its future enhancement with accuracy-boosting technologies such as computer-aided detection.
For more information from the Diagnostic Imaging archives:
CMS commences national coverage analysis for CT colonography
CT colonography experts plan for growing demand
CAD provides value in spotting difficult 'flat' colonic lesions
CT installed base can handle demand for colon cancer screening
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
